Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7 CHF | 0.00% | -3.45% | +41.41% |
Apr. 17 | Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member | CI |
Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+41.41% | 143M | |
-2.86% | 87.31B | |
+3.95% | 40.86B | |
-21.94% | 29.36B | |
+53.17% | 24.49B | |
-5.41% | 17.31B | |
-44.23% | 11.26B | |
-17.60% | 11.62B | |
-13.96% | 11.31B | |
-0.22% | 8.31B |
- Stock Market
- Equities
- NWRN Stock
- News Newron Pharmaceuticals S.p.A.
- Newron Pharmaceuticals S p A : Gets US FDA Notice Regarding Approval For Safinamide